November 02, 2022
Dr. Henn is Established Academic Leader with Strong Track Record of Success in Research and Clinical Care; Led Department鈥檚 Residency Program to Become Among Top in the Nation
University of Maryland School of BOB体育 (UMSOM) Dean Mark T. Gladwin, MD, announced today that R. Frank Henn, III, MD, Professor of Orthopaedics, has been appointed to serve as the Interim Chair of UMSOM鈥檚 Department of Orthopaedics, effective December 1, 2022.
Dr. Henn assumes the position formerly held for the past ten years by Andrew N. Pollak, MD, the James Lawrence Kernan Professor of Orthopaedics, who was appointed Senior Vice President and Chief Clinical Officer (CCO) of the University of Maryland Medical System (UMMS) in May 2022.
Dr. Henn, who joined the Department in 2010, is an academic leader and highly regarded, board-certified orthopaedic surgeon who has published significant scientific research, and is a leading clinician focusing on the care of the shoulder, knee, and ankle, with an emphasis in cartilage restoration and joint repair techniques.
鈥淒r. Henn has an outstanding track record of success in scientific research, clinical care and education,鈥� said Mark T. Gladwin, MD, Vice President for Medical Affairs, University of Maryland, Baltimore, and the John Z. and Akiko K. Bowers Distinguished Professor and Dean, University of Maryland School of BOB体育. 鈥淗e has already made a significant impact with his contributions to research in knee injury and patient outcomes, his clinical expertise in autologous chondrocyte implantation and complex reconstruction of the shoulder and knee, and he has built a nationally recognized residency program. Dr. Henn is well suited to lead the Department as Interim Chair.鈥�
Dr. Henn is actively engaged in research efforts, most recently as the Principal Investigator of the 鈥淥utcomes of Multi-ligament Knee Injuries鈥� study funded by the Foundation for Orthopedic Trauma, and the 鈥淢aryland Orthopaedic and Sports BOB体育 Research Registry鈥� study funded by a Kernan Endowment grant.
He has published 112 peer-reviewed scientific papers with a focus on patients' expectations, satisfaction, and surgical outcomes. These include five studies regarding Press-Ganey patient satisfaction surveys after orthopaedic surgery. His paper published in the Journal of Bone and Joint Surgery in 2021 demonstrated significant disparities in patient populations that complete patient satisfaction surveys, raising concerns that response bias may limit interpretation of survey results. He also has developed a new metric for assessing patient-based outcomes that involves asking patients if they are 鈥榗ompletely better鈥� after orthopaedic surgery. The first study using this metric after ACL reconstruction was published in the American Journal of Sports BOB体育 this year.
Dr. Henn鈥檚 exemplary leadership as the Department鈥檚 Residency Director since 2013 has resulted in that program鈥檚 present recognition as one of the top orthopaedic residencies in the nation. 鈥淲e have a reputation for training outstanding surgeons who have many opportunities for achievement in clinical care, research, and mentorship,鈥� said Dr. Henn. In 2022 alone, the program had more than 1,000 applicants vying for just six resident positions. Dr. Henn also introduced a formal resident research curriculum in 2017 that has produced significant results, with resident publications in recognized scientific journals increasing over the past five years, and one resident awarded a research grant from the Orthopaedic Research and Education Foundation (OREF), a leading resource for new investigators. Most recently, he was able to successfully maintain the program鈥檚 momentum during the COVID pandemic through the rapid introduction of a flexible online lecture format and a realigned rotation schedule to minimize resident exposure to the virus while continuing their training.
Clinically, he is highly experienced in the field of sports medicine. Dr. Henn has served as a physician for a number of prominent professional and collegiate sports teams, including the New England Patriots, the Boston Bruins, the Boston Red Sox, and currently serves as a team orthoaedic surgeon for the UMBC Retrievers, University of Maryland Terrapins, and the Baltimore Nighthawks.
Under Dr. Pollak's leadership, the Department of Orthopaedics at UMSOM made significant advances in recent years, including growth in market share, research funding, improved quality metrics, improvements and growth in educational programs, and expansion of clinical services. In particular, the Department is now among the nation鈥檚 top ten programs for annual federal and private research funding. Overall, funding for the Department has grown sixfold ($2M to $12M) from 2016 to 2020, with an annual growth rate of 85 percent in NIH funding from FY12 ($316k) to FY21 ($3.0M). The Department also recently set worldwide practice standards in clinical investigations with the two largest orthopaedic trauma trials ever conducted, including one that completed the enrollment of 12,200 patients from 21 trauma centers in the US and Canada, on time and on budget.
Dr. Henn has been recognized by Baltimore Magazine as a "Top Doctor" for five consecutive years, starting in 2017, and also has been honored with the Neer Award in Clinical Science from the American Shoulder and Elbow Surgeons, and the Achilles Research Award from the International Society of Arthroscopy, Knee Surgery and Orthopaedic Sports BOB体育 (ISAKOS). He is currently an Active Member of the Orthopaedic Research Society, the Arthroscopy Association of North America, and the American Orthopaedic Society for Sports BOB体育, as well as a Fellow of the American Orthopaedic Association, among others.
After earning his medical degree at Brown University, Dr. Henn completed his internship in General Surgery at New York Presbyterian Hospital, Cornell, followed by a residency in orthopaedic surgery at the Hospital for Special Surgery (NYC), and fellowships in Sports BOB体育 at Massachusetts General Hospital, and at the Cartilage Repair Center at Brigham & Women鈥檚 Hospital (Boston).
鈥淚t is an honor to have the opportunity to lead this distinguished department, and I look forward to building on the successful leadership of Dr. Pollak,鈥� said Dr. Henn. 鈥淢y goals are to expand access to outstanding interdisciplinary musculoskeletal care, grow our exceptional research program, and provide optimal educational experiences for students and trainees.鈥�
Contact
Office of Public Affairs
655 West Baltimore Street
Bressler Research Building 14-002
Baltimore, Maryland 21201-1559
Contact Media Relations
(410) 706-5260
Related stories
Friday, February 07, 2025
UM School of BOB体育 Surgeon-Scientist to Co-Lead Large International Clinical Trial to Determine Most Effective Treatment for Common Hip Fracture in Older Adults
Hip fractures in older adults can lead to serious complications, disability and even death. Traditionally, orthopaedic surgeons have repaired a common fracture of the upper part of the thigh bone, or femur, near the hip using screws and plates to piece together slightly separated pieces of bone. But many surgeons now treat these “minimally displaced” femoral neck fractures by replacing the hip joint with a metal implant.
Thursday, July 25, 2024
Orthopaedic Surgeon-Scientist Dr. Frank Henn Named Chair of the Department of Orthopaedics
University of Maryland School of BOB体育 Dean Mark T. Gladwin, MD, announced today that R. Frank Henn, III, MD, Professor of Orthopaedics, who has served as Interim Chair of the Department since 2022, has been appointed to serve as the new Chair of UMSOM’s Department of Orthopaedics, effective immediately.
Wednesday, January 31, 2024
Large Multicenter Clinical Trial Finds that Antiseptic Containing Iodine Reduces Surgical-Site Infections in Patients with Extremity Fractures
A large multicenter clinical trial co-led by University of Maryland School of BOB体育 researchers found that an antiseptic containing iodine resulted in about one-quarter fewer post-surgical infections in patients with limb fractures compared to another frequently used skin antiseptic. The results of the study of nearly 8,500 patients across the United States and Canada were published today in the New England Journal of BOB体育.
Wednesday, January 18, 2023
Aspirin as Effective as Blood Thinner Injections to Prevent Deadly Complications in Patients Hospitalized with Bone Fractures
Patients hospitalized with fractures typically receive an injectable blood thinner, low-molecular-weight heparin, to prevent life-threatening blood clots. A new clinical trial, however, found that inexpensive over-the-counter aspirin is just as effective. The findings, published today in the New England Journal of BOB体育, may lead surgeons to change their practice and administer aspirin to these patients.
Thursday, October 13, 2022
Landmark Clinical Study Finds Aspirin as Effective as Commonly Used Blood Thinner to Prevent Life-Threatening Blood Clots and Death After Fracture Surgery
Patients who have surgery to repair bone fractures typically receive a type of injectable blood thinner, low-molecular-weight heparin, to prevent life-threatening blood clots, but a new clinical trial found that over-the-counter aspirin is just as effective. The findings, presented today at the Orthopaedic Trauma Association (OTA) annual meeting in Tampa, FL, could cause surgeons to change their practice and administer aspirin instead to these patients.
Tuesday, December 05, 2017
University of Maryland School of BOB体育 Orthopaedic Surgeons to Receive Prestigious International Research Award
A research team led by Mohit N. Gilotra, MD, assistant professor of orthopaedics at the University of Maryland School of BOB体育 (UMSOM), will receive the prestigious 2018 Charles S. Neer Award from the American Shoulder and Elbow Surgeons (ASES) for a clinical study that demonstrated an effective method to potentially reduce the risk of serious infection following shoulder surgery.